Primary central nervous system lymphoma (PCNSL) accounts for only 1% of all lymphoma diagnoses and between 0.8% to 6.6% of all central nervous system (CNS) neoplasms. 1 Most CNS tumors involve the supratentorial space (60%); in these tumors, the posterior fossa (13%) is less commonly involved and the spinal cord (1%) is rarely involved. 1, 2 Moreover, spinal cord neoplasms are generally uncommon. These lesions are classified as intramedullary (occurring within the spinal cord parenchyma) or extramedullary (occurring outside the spinal cord). Intramedullary spinal tumors account for 5% to 10% of spinal tumors, most of which are glial in origin; an extremely small percentage of these are lymphomas. 3 This finding contrasts with that of spinal involvement in systemic lymphoma, in which diffuse leptomeningeal involvement and extradural nodules are usually present. 
Case Report
An 82-year-old white man reported progressive lower back pain and weakness of the lower extremities over a period of 1 year. Magnetic resonance imaging (MRI) of the thoracic and lumbar spine showed a signal abnormality from T7, the conus medullaris, with clumping and enhancement of the cauda equina. The patient had a full neurological workup, including lumbar punctures that tested negative for malignant neoplasms but positive for acute inflammatory cells consistent with meningitis. We also performed a head computed tomography (CT) scan that revealed no evidence of acute intracranial abnormality or acute territorial infarction. The patient underwent nerve-conduction studies and needle electromyography (EMG) for both lower extremities. 
Discussion
PCNSL accounts for less than 1% of lymphoma diagnoses, and the T-cell phenotype is found in less than 1% of PCNSL cases. 3, 5 Hence, there are few reported cases in the literature of PCNSL of T-cell type. Moreover, primary spinal involvement is exceptionally rare, occurring in less than 1% of patients with PCNSL. [3] [4] [5] [6] From a histological standpoint, T-cell lymphomas are a heterogeneous group of neoplasms that may be difficult to diagnose using morphologic and immunophenotypic criteria. 7, 8 Some of these less common lymphomas do not bear the obvious cytologic atypia of malignancy, or the malignant cytology is obscured by an abundance of nonneoplastic inflammatory cells. A spectrum of cell sizes and types are typically found in these lymphomas, including nonneoplastic cells, making it problematic to differentiate T-cell lymphomas from reactive
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Spinal magnetic resonance imaging (MRI) scan of thoracolumbar region of the patient, an 82-year-old white man, demonstrating T2 hyperintensity. Immunohistochemical staining is useful to determine the cell lineage, in which these atypical lymphoma T cells are immunoreactive for CD3 and for any combination of CD2, CD4, CD5, CD7, and/or CD8. Also, TCR gene rearrangement by PCR analysis may demonstrate a clonal TCR gene rearrangement and has been shown to be a useful method for determining the clonality of neoplastic cells.
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When primary spinal cord involvement of lymphoma occurs, the lesions are almost always intramedullary spinal cord lesions. This finding contrasts with spinal involvement in systemic lymphoma, in which there is usually diffuse leptomeningeal involvement and extradural nodules. [4] [5] [6] Clinically, patients usually display progressive myelopathic manifestations; the pattern of weakness and sensory loss will depend on the localization and extent of the lesion. Most reported cases of primary spinal lymphoma have involved the lower cervical and upper thoracic regions. 6 A retrospective analysis performed by the Mayo Clinic 6 showed that most patients with primary intramedullary spinal cord lymphoma displayed multifocal and persistently enhancing lesions on spinal MRI. Also, more than half of these patients had involvement of the conus medullaris and/or cauda equina. Spinal cord expansile lesions have been noted in many of these patients. Also, it has been reported that all patients initially harbored progressive myelopathic manifestations. 6 The diagnosis of primary intramedullary spinal cord lymphoma is often delayed due to the broadness of the differential diagnoses for myelopathy as well as the rarity of this condition. 2, 3, 6 A high percentage of patients have additional signs and symptoms that include systemic B symptoms, back pain, and evidence of lower-body motor-neuron involvement.
6-9
The clinical appearance and findings on MRI of primary intramedullary spinal cord lymphoma are nonspecific; other intracranial processes, such as multiple sclerosis, sarcoidosis, and occasionally gliomas, have a similar appearance on MRI. 3,9 MRI findings are usually isointense to hypointense on T1-weighted images and hypointense on T2-weighted images. Further, the CSF test results are usually inconclusive. [3] [4] [5] 9 This raises the question of when to suspect the diagnosis of PCNSL of the spinal cord because biopsy is required for proper pathologic diagnosis and delayed treatment usually results in death. [9] [10] [11] PCNSL is sensitive to chemotherapy and radiotherapy; however, the overall response rates and long-term survival are significantly inferior to the results achieved in similar subtypes of extranodal non-Hodgkin lymphoma (NHL). [8] [9] [10] [11] Patients should be encouraged to enroll in a clinical trial for PCNSL and should seek histopathologic confirmation of their diagnosis 9 Histopathologic confirmation of the diagnosis is critical because in a subset of patients, a presumptive but incorrect diagnosis of PCNSL is given based on MRI appearance and tumor response to corticosteroids. However, tissue diagnosis is essential because of other intracranial processes that yield similar MRI findings and also result in a transient response to corticosteroids.
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The recommended diagnostic procedure for PCNSL is a stereotactic needle biopsy because patients derive no additional clinical benefit from surgical resection. Also, the deep-seated nature of most lesions makes resection impossible or increases the risk of surgical complications.
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Image 3
Staining of perivascular large atypical lymphocytes with an associated necrotizing vasculitis in thte patient, an 82-year-old white man (hematoxylin-eosin, original magnification ×200x).
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